Evidence map›Paper›PMID 26834026›Full record

ArticleSchizophrenia bulletin2016

Working Memory Deficit as a Risk Factor for Severe Apathy in Schizophrenia: A 1-Year Longitudinal Study.

Stéphane Raffard, Laure-Anne Gutierrez, Hanan Yazbek, Aurore Larue, Jean-Philippe Boulenger, Christophe Lançon, Michel Benoit, Catherine Faget, Joanna Norton, Delphine Capdevielle

Abstract read
In one paragraph

Article in Schizophrenia bulletin, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stéphane RaffardUniversity Department of Adult Psychiatry, Hôpital de la Colombière, CHRU Montpellier, Montpellier, France; Epsylon Laboratory Dynamic of Human Abilities & Health Behaviors, University of Montpellier 3, Montpellier, France; s-raffard@chu-montpellier.fr.
Laure-Anne GutierrezUniversity Department of Adult Psychiatry, Hôpital de la Colombière, CHRU Montpellier, Montpellier, France; U1061: Neuropsychiatry: Epidemiological and Clinical Research, INSERM U1061, Montpellier, France; U1061: Neuropsychiatry: Epidemiological and Clinical Research, University of Montpellier, Montpellier, France.
Hanan YazbekUniversity Department of Adult Psychiatry, Hôpital de la Colombière, CHRU Montpellier, Montpellier, France; Epsylon Laboratory Dynamic of Human Abilities & Health Behaviors, University of Montpellier 3, Montpellier, France;
Aurore LarueUniversity Department of Adult Psychiatry, Hôpital de la Colombière, CHRU Montpellier, Montpellier, France;
Jean-Philippe BoulengerUniversity Department of Adult Psychiatry, Hôpital de la Colombière, CHRU Montpellier, Montpellier, France;
Christophe LançonAix-Marseille University, EA 3279-Public Health, Chronic Diseases and Quality of Life-Research Unit, Marseille, France;
Michel BenoitPsychiatry-Clinical Neuroscience Department, Pasteur Hospital, University of Nice Sophia-Antipolis, Nice, France.
Catherine FagetAix-Marseille University, EA 3279-Public Health, Chronic Diseases and Quality of Life-Research Unit, Marseille, France;
Joanna NortonU1061: Neuropsychiatry: Epidemiological and Clinical Research, INSERM U1061, Montpellier, France; U1061: Neuropsychiatry: Epidemiological and Clinical Research, University of Montpellier, Montpellier, France.
Delphine CapdevielleUniversity Department of Adult Psychiatry, Hôpital de la Colombière, CHRU Montpellier, Montpellier, France; U1061: Neuropsychiatry: Epidemiological and Clinical Research, INSERM U1061, Montpellier, France; U1061: Neuropsychiatry: Epidemiological and Clinical Research, University of Montpellier, Montpellier, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apathy, described as impaired motivation and goal-directed behavior, is a common yet often overlooked multidimensional psychopathological state in schizophrenia. Its underlying cognitive processes remain largely unexplored. Data was drawn from a longitudinal hospital study of patients with a DSM-IV diagnosis of schizophrenia; 137 (82.5%) participated at the 1-month follow-up and 81 (59.1%) at the 1-year follow-up. Apathy was assessed with the Lille Apathy Rating Scale, validated in French and in schizophrenia. Severe apathy, overall (total score > -13) and on 4 previously identified distinct dimensions, was considered. Episodic verbal learning was assessed with the California Verbal Learning Test, executive functioning with the Trail Making Test, the Six Element Test and the Stop Signal Paradigm and working memory with the Letter-Number Sequencing Test. After controlling for confounding variables, only episodic verbal learning was associated with severe overall apathy in the cross-sectional study. At 1 year, working memory was associated with an increased risk of severe overall apathy, adjusting for baseline apathy. Using a dimensional approach to apathy, specific types of cognition were found to be associated with specific dimensions of apathy. Our findings confirm the need for a multidimensional approach of negative symptoms in schizophrenia. Moreover, cognitive functioning could be a risk factor for developing severe apathy. Cognitive remediation may thus be a useful non-pharmacological intervention for treating apathy in schizophrenia patients.

Indexed as

AdultApathyFemaleHumansLongitudinal StudiesMaleMemory DisordersMemory, Short-TermMiddle AgedRisk FactorsSchizophreniaYoung Adultapathycognitionlongitudinal studynegative symptoms

Identifiers

PMID26834026
PMCPMC4838112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.